Thermo Fisher Scientific Hits Day High with 5.2% Surge in Stock Price

Thermo Fisher Scientific, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge today, gaining 5.2% as of June 9, 2026. The stock reached an intraday high of USD 494.36, reflecting strong market activity. In terms of performance metrics, Thermo Fisher has shown resilience over various time frames. Over the past month, the stock has increased by 6.25%, outperforming the S&P 500, which saw a slight decline of 0.17%. Year-to-date, however, the stock is down 14.73%, contrasting with the S&P 500's gain of 7.91%. The company's financial health is underscored by a robust EBIT to Interest ratio of 11.00, indicating a strong capacity to manage its debt. Additionally, Thermo Fisher has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 10.48% and operating profit at 11.37%. With a market capitalization of USD 197 billion and a P/E ratio of 28.00, Thermo Fisher Scientific continues to maintain a competitive position in the market, supported by a solid return on equity of 13.09%.